{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:28:41Z","timestamp":1787318921023,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.rbmo.2020.03.023","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T04:03:01Z","timestamp":1588219381000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The performance of the Elecsys\u00ae anti-M\u00fcllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3417-5736","authenticated-orcid":false,"given":"Ana Raquel","family":"Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Blockeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Griesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Garcia-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio La","family":"Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6586-0111","authenticated-orcid":false,"given":"Ignacio","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Drakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Tournaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus P","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2020.03.023_bib0001","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejogrb.2019.02.022","article-title":"Evaluation of the Elecsys\u00ae anti-M\u00fcllerian hormone assay for the prediction of hyper-response to controlled ovarian stimulation with a gonadotrophin-releasing hormone antagonist protocol","volume":"236","author":"Anckaert","year":"2019","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology,"},{"issue":"3","key":"10.1016\/j.rbmo.2020.03.023_bib0002","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clinbiochem.2015.10.008","article-title":"Multicenter analytical performance evaluation of a fully automated anti-M\u00fcllerian hormone assay and reference interval determination","volume":"49","author":"Anckaert","year":"2016","journal-title":"Clinical Biochemistry"},{"issue":"6","key":"10.1016\/j.rbmo.2020.03.023_bib0003","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/humrep\/des101","article-title":"The value of anti-Mllerian hormone measurement in the long GnRH agonist protocol: Association with ovarian response and gonadotrophin-dose adjustments","volume":"27","author":"Anckaert","year":"2012","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1016\/j.rbmo.2020.03.023_bib0004","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.fertnstert.2015.01.004","article-title":"Prospective study into the value of the automated Elecsys antim\u00fcllerian hormone assay for the assessment of the ovarian growing follicle pool","volume":"103","author":"Anderson","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1016\/j.rbmo.2020.03.023_bib0005","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.fertnstert.2018.03.031","article-title":"Multicenter evaluation of the Access AMH antim\u00fcllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation","volume":"110","author":"Baker","year":"2018","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1016\/j.rbmo.2020.03.023_bib0006","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fertnstert.2015.04.018","article-title":"Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation pr","volume":"104","author":"Boostanfar","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1016\/j.rbmo.2020.03.023_bib0007","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: Ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Human Reproduction Update"},{"issue":"1","key":"10.1016\/j.rbmo.2020.03.023_bib0008","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: A meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Human Reproduction Update"},{"issue":"1","key":"10.1016\/j.rbmo.2020.03.023_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/uog.18945","article-title":"Counting ovarian antral follicles by ultrasound: a practical guide","volume":"51","author":"Coelho Neto","year":"2018","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"11","key":"10.1016\/j.rbmo.2020.03.023_bib00010","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/humrep\/den288","article-title":"A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation","volume":"23","author":"Corifollitropin Alfa Dose-finding Study Group","year":"2008","journal-title":"Human Reproduction"},{"issue":"12","key":"10.1016\/j.rbmo.2020.03.023_bib00011","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1016\/j.rbmo.2020.03.023_bib00012","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1016\/j.rbmo.2020.03.023_bib00013","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn065","article-title":"Advances in recombinant DNA technology: Corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency","volume":"15","author":"Fauser","year":"2009","journal-title":"Human Reproduction Update"},{"issue":"7","key":"10.1016\/j.rbmo.2020.03.023_bib00014","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Human Reproduction"},{"issue":"8","key":"10.1016\/j.rbmo.2020.03.023_bib00015","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1515\/cclm-2014-0022","article-title":"First fully automated immunoassay for anti-M\u00fcllerian hormone","volume":"52","author":"Gassner","year":"2014","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"5","key":"10.1016\/j.rbmo.2020.03.023_bib00016","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10815-018-1141-5","article-title":"Multi-center clinical evaluation of the Access AMH assay to determine AMH levels in reproductive age women during normal menstrual cycles","volume":"35","author":"Gracia","year":"2018","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"10.1016\/j.rbmo.2020.03.023_bib00017","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rbmo.2016.04.005","article-title":"Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis","volume":"33","author":"Griesinger","year":"2016","journal-title":"Reproductive BioMedicine Online"},{"issue":"6","key":"10.1016\/j.rbmo.2020.03.023_bib00018","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-M\u00fcllerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Human Reproduction Update"},{"issue":"8","key":"10.1016\/j.rbmo.2020.03.023_bib00019","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/humrep\/dex219","article-title":"Non-equivalence of anti-M\u00fcllerian hormone automated assays - Clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing","volume":"32","author":"Iliodromiti","year":"2017","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2020.03.023_bib00020","doi-asserted-by":"crossref","unstructured":"Jacobs, M. H., Reuter, L. M., Baker, V. L., Craig, L. B., Sakkas, D., Surrey, E., \u2026 Timm, B. (2019). A multicentre evaluation of the Elecsys\u00ae anti-M\u00fcllerian hormone immunoassay for prediction of antral follicle count. Reproductive BioMedicine Online, (pii), S1472-6483(19)30006-9.https:\/\/doi.org\/10.1016\/j.rbmo.2018.12.041","DOI":"10.1016\/j.rbmo.2018.12.041"},{"issue":"8","key":"10.1016\/j.rbmo.2020.03.023_bib00021","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/humrep\/deu142","article-title":"Biological variability in serum anti-M\u00fcllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women","volume":"29","author":"Kissell","year":"2014","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1016\/j.rbmo.2020.03.023_bib00022","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: From theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Human Reproduction Update"},{"issue":"1","key":"10.1016\/j.rbmo.2020.03.023_bib00023","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fertnstert.2015.09.033","article-title":"Levels of antim\u00fcllerian hormone in serum during the normal menstrual cycle","volume":"105","author":"Lambert-Messerlian","year":"2016","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2020.03.023_bib00024","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.rbmo.2020.03.023_bib00025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.rbmo.2017.02.012","article-title":"Ovarian response to 150 \u00b5g corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study","volume":"34","author":"Lerman","year":"2017","journal-title":"Reproductive BioMedicine Online"},{"issue":"12","key":"10.1016\/j.rbmo.2020.03.023_bib00026","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1093\/humrep\/dew248","article-title":"Commercial immunoassays for anti-M\u00f6llerian hormonemeasurement","volume":"31","author":"Li","year":"2016","journal-title":"Human Reproduction"},{"issue":"8","key":"10.1016\/j.rbmo.2020.03.023_bib00027","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3109\/09513590.2013.801443","article-title":"Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors?","volume":"29","author":"Mart\u00ednez","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1016\/j.rbmo.2020.03.023_bib00028","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.rbmo.2016.04.012","article-title":"Variation in antral follicle counts at different times in the menstrual cycle: does it matter?","volume":"33","author":"Mavrelos","year":"2016","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1016\/j.rbmo.2020.03.023_bib00029","doi-asserted-by":"crossref","first-page":"b375","DOI":"10.1136\/bmj.b375","article-title":"Prognosis and prognostic research: what, why, and how?","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.rbmo.2020.03.023_bib00030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1016\/j.rbmo.2020.03.023_bib00031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-015-0113-1","article-title":"Predictive factors for ovarian response in a corifollitropin alfa\/GnRH antagonist protocol for controlled ovarian stimulation in IVF\/ICSI cycles","volume":"13","author":"Oehninger","year":"2015","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"S1","key":"10.1016\/j.rbmo.2020.03.023_bib00032","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S1472-6483(11)60012-6","article-title":"Individualizing FSH dose for assisted reproduction using a novel algorithm: The CONSORT study","volume":"22","author":"Olivennes","year":"2011","journal-title":"Reproductive BioMedicine Online"},{"issue":"12","key":"10.1016\/j.rbmo.2020.03.023_bib00033","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/humrep\/dex319","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 2: The predicted hyper responder","volume":"32","author":"Oudshoorn","year":"2017","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1016\/j.rbmo.2020.03.023_bib00034","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.fertnstert.2013.03.031","volume":"100","author":"Polyzos","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1016\/j.rbmo.2020.03.023_bib00035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.fertnstert.2013.04.029","article-title":"Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization\/intracytoplasmic sperm injection","volume":"100","author":"Polyzos","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1016\/j.rbmo.2020.03.023_bib00036","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/humrep\/deg472","article-title":"A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a \u201cstandard\u201d dose of 150 IU\/day in \u201cstandard\u201d patients undergoing IVF\/ICSI treatment","volume":"18","author":"Popovic-Todorovic","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2020.03.023_bib00037","article-title":"Long\u2010acting FSH versus daily FSH for women undergoing assisted reproduction","volume":"7","author":"Pouwer","year":"2015","journal-title":"Database of Systematic Reviews"},{"issue":"6","key":"10.1016\/j.rbmo.2020.03.023_bib00038","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.fertnstert.2011.09.005","article-title":"The predictive value of antral follicle count remains unchanged across the menstrual cycle","volume":"96","author":"Rombauts","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1016\/j.rbmo.2020.03.023_bib00039","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/humrep\/dey236","article-title":"Performance of prognostic modeling of high and low ovarian response to ovarian stimulation for IVF","volume":"33","author":"Scheinhardt","year":"2018","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1016\/j.rbmo.2020.03.023_bib00040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: An analysis of 256,381 in vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1016\/j.rbmo.2020.03.023_bib00041","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1016\/j.rbmo.2020.03.023_bib00042","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter-and intra-cycle variability of anti-M\u00fcllerian hormone and antral follicle counts","volume":"25","author":"Van Disseldorp","year":"2010","journal-title":"Human Reproduction"},{"issue":"12","key":"10.1016\/j.rbmo.2020.03.023_bib00043","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/dex318","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 1: The predicted poor responder","volume":"32","author":"van Tilborg","year":"2017","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2020.03.023_bib00044","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2147\/DDDT.S104104","article-title":"PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome","volume":"10","author":"Yovich","year":"2016","journal-title":"Drug Design, Development and Therapy"},{"issue":"1","key":"10.1016\/j.rbmo.2020.03.023_bib00045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rbmo.2017.09.017","article-title":"Finding a place for corifollitropin within the PIVET FSH dosing algorithms","volume":"36","author":"Yovich","year":"2018","journal-title":"Reproductive BioMedicine Online"},{"issue":"3","key":"10.1016\/j.rbmo.2020.03.023_bib00046","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.repbio.2013.04.005","article-title":"Within-laboratory and between-laboratory variability in the measurement of anti-m\u00fcllerian hormone determined within an external quality assurance scheme","volume":"13","author":"Zuvela","year":"2013","journal-title":"Reproductive Biology"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320301784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320301784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:18:51Z","timestamp":1761466731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648320301784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1472648320301784"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.03.023","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The performance of the Elecsys\u00ae anti-M\u00fcllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}